BACKGROUND: Newly diagnosed people with multiple sclerosis frequently report fatigue, pain, depression and anxiety. Preventative programmes may be beneficial, but there is limited evidence of their effectiveness, especially long-term follow-up. METHODS: The programme consisted of 6-month face to face intervention (an introductory workshop, psychology-led group sessions and individual physical therapy) followed by 6-month self-guided therapy. Outcome measures were taken at baseline, 6 and 12 months. Primary outcomes measures were self-report questionnaires for fatigue, satisfaction with life and disease acceptance. Secondary outcomes were spirometry, spiroergometric parameters and neuroactive steroid levels. RESULTS: From 22 participants enrolled, 17 completed the first 6 months and 13 the follow-up. Fatigue measured on the Fatigue scale for motor and cognitive functions decreased significantly at 6 months (p = 0.035) and at follow-up (p = 0.007). The Modified Fatigue Impact Scale (p = 0.035) and Satisfaction With Life Scale (p = 0.007) significantly increased at follow-up. Spirometry, spiroergometric parameters, steroid hormones and neuroactive steroids levels did not change significantly. CONCLUSION: This programme reduces fatigue and improves satisfaction with life in this patient group with improvements sustained at 12 months. People who participated more frequently showed greater benefit. CLINICAL REHABILITATION IMPACT: The paper describes the effects of a complex preventative intervention for people with newly diagnosed Multiple Sclerosis. The study found that this programme reduces fatigue and improves satisfaction with life with long-term benefit (at 12-month follow up). The individuals who participated less frequently experienced fewer benefits.

Department of Applied Ecology Faculty of Environmental Sciences Czech University of Life Sciences Prague Czechia

Department of Neurology 3rd Faculty of Medicine Charles University University Hospital Kralovske Vinohrady Prague Czechia

Department of Rehabilitation Medicine 3rd Faculty of Medicine Charles University Prague Czechia

Department of Steroids and Proteofactors Institute of Endocrinology Prague Czechia

Mediterra s r o Malvazinky Rehabilitation Clinic Prague Czechia

MS Research Treatment and Education The Vassall Centre Bristol United Kingdom

Zobrazit více v PubMed

Brochet B, Deloire MS, Ouallet JC, Salort E, Bonnet M, Jové J, et al. . Pain and quality of life in the early stages after multiple sclerosis diagnosis: a 2-year longitudinal study. Clin J Pain. (2009) 25:211–7. doi: 10.1097/AJP.0b013e3181891347, PMID: PubMed DOI

de Groot V, Beckerman H, Lankhorst GJ, Polman CH, Bouter LM. The initial course of daily functioning in multiple sclerosis: a three-year follow-up study. Mult Scler. (2005) 11:713–8. doi: 10.1191/1352458505ms1238oa PubMed DOI

Runia TF, Jafari N, Siepman DA, Hintzen RQ. Fatigue at time of CIS is an independent predictor of a subsequent diagnosis of multiple sclerosis. J Neurol Neurosurg Psychiatry. (2015) 86:543–6. doi: 10.1136/jnnp-2014-308374 PubMed DOI

Valentine TR, Alschuler KN, Ehde DM, Kratz AL. Prevalence, co-occurrence, and trajectories of pain, fatigue, depression, and anxiety in the year following multiple sclerosis diagnosis. Mult Scler. (2021) 28:620–31. doi: 10.1177/13524585211023352 PubMed DOI

Lode K, Bru E, Klevan G, Myhr KM, Nyland H, Larsen JP. Depressive symptoms and coping in newly diagnosed patients with multiple sclerosis. Mult Scler. (2009) 15:638–43. doi: 10.1177/1352458509102313 PubMed DOI

Janssens AC, van Doorn PA, de Boer JB, van der Meché FG, Passchier J, Hintzen RQ. Impact of recently diagnosed multiple sclerosis on quality of life, anxiety, depression and distress of patients and partners. Acta Neurol Scand. (2003) 108:389–95. doi: 10.1034/j.1600-0404.2003.00166.x, PMID: PubMed DOI

Klevan G, Jacobsen CO, Aarseth JH, Myhr KM, Nyland H, Glad S, et al. . Health related quality of life in patients recently diagnosed with multiple sclerosis. Acta Neurol Scand. (2014) 129:21–6. doi: 10.1111/ane.12142 PubMed DOI

Marck CH, De Livera AM, Weiland TJ, Jelinek PL, Neate SL, Brown CR, et al. . Pain in people with multiple sclerosis: associations with modifiable lifestyle factors, fatigue, depression, anxiety, and mental health quality of life. Front Neurol. (2017) 8:461. doi: 10.3389/fneur.2017.00461, PMID: PubMed DOI PMC

Wollin J, Dale H, Spenser N, Walsh A. What people with newly diagnosed MS (and their families and friends) need to know. Int J MS Care. (2000) 2:29–39. doi: 10.7224/1537-2073-2.3.29 DOI

Solari A, Martinelli V, Trojano M, Lugaresi A, Granella F, Giordano A, et al. . An information aid for newly diagnosed multiple sclerosis patients improves disease knowledge and satisfaction with care. Mult Scler. (2010) 16:1393–405. doi: 10.1177/1352458510380417 PubMed DOI

Köpke S, Kern S, Ziemssen T, Berghoff M, Kleiter I, Marziniak M, et al. . Evidence-based patient information programme in early multiple sclerosis: a randomised controlled trial. J Neurol Neurosurg Psychiatry. (2014) 85:411–8. doi: 10.1136/jnnp-2013-306441 PubMed DOI

Köpke S, Solari A, Khan F, Heesen C, Giordano A. Information provision for people with multiple sclerosis. Cochrane Database Syst Rev. (2014) 4:Cd008757. doi: 10.1002/14651858.CD008757.pub2 PubMed DOI

Calandri E, Graziano F, Borghi M, Bonino S. Improving the quality of life and psychological well-being of recently diagnosed multiple sclerosis patients: preliminary evaluation of a group-based cognitive behavioral intervention. Disabil Rehabil. (2017) 39:1474–81. doi: 10.1080/09638288.2016.1198430 PubMed DOI

Heidari-Soureshjani R, Nasrabadi AN, Zakerimoghadam M, Mohammadi T, Rasti A. Self-management interventions for people with multiple sclerosis: a systematic review and meta-analysis protocol. Health Sci Rep. (2023) 6:e1536. doi: 10.1002/hsr2.1536, PMID: PubMed DOI PMC

Sesel A-L, Sharpe L, Beadnall HN, Barnett MH, Szabo M, Naismith SL. A randomized controlled trial of a web-based mindfulness programme for people with MS with and without a history of recurrent depression. Mult Scler J. (2022) 28:1392–401. doi: 10.1177/13524585211068002 PubMed DOI

Montañés-Masias B, Bort-Roig J, Pascual JC, Soler J, Briones-Buixassa L. Online psychological interventions to improve symptoms in multiple sclerosis: a systematic review: online psychological interventions in multiple sclerosis. Acta Neurol Scand. (2022) 146:448–64. doi: 10.1111/ane.13709 PubMed DOI PMC

Angelova G, Skodova T, Prokopiusova T, Markova M, Hruskova N, Prochazkova M, et al. . Ambulatory Neuroproprioceptive facilitation and inhibition physical therapy improves clinical outcomes in multiple sclerosis and modulates serum level of neuroactive steroids: a two-arm parallel-group exploratory trial. Life. (2020) 10:267. doi: 10.3390/life10110267 PubMed DOI PMC

Rietberg MB, van Wegen EE, Eyssen IC, Kwakkel G. Effects of multidisciplinary rehabilitation on chronic fatigue in multiple sclerosis: a randomized controlled trial. PLoS One. (2014) 9:e107710. doi: 10.1371/journal.pone.0107710 PubMed DOI PMC

Thomas PW, Thomas S, Kersten P, Jones R, Slingsby V, Nock A, et al. . One year follow-up of a pragmatic multi-Centre randomised controlled trial of a group-based fatigue management programme (FACETS) for people with multiple sclerosis. BMC Neurol. (2014) 14:109. doi: 10.1186/1471-2377-14-109 PubMed DOI PMC

Rasova K, Brandejsky P, Havrdova E, Zalisova M, Rexova P. Spiroergometric and spirometric parameters in patients with multiple sclerosis: are there any links between these parameters and fatigue, depression, neurological impairment, disability, handicap and quality of life in multiple sclerosis? Mult Scler. (2005) 11:213–21. doi: 10.1191/1352458505ms1155oa, PMID: PubMed DOI

Rasova K, Havrdova E, Brandejsky P, Zálisová M, Foubikova B, Martinkova P. Comparison of the influence of different rehabilitation programmes on clinical, spirometric and spiroergometric parameters in patients with multiple sclerosis. Mult Scler. (2006) 12:227–34. doi: 10.1191/135248506ms1248oa, PMID: PubMed DOI

Honcu P, Zach P, Mrzilkova J, Jandova D, Musil V, Celko AM. Computer kinesiology: new diagnostic and therapeutic tool for lower Back pain treatment (pilot study). Biomed Res Int. (2020) 2020:1–10. doi: 10.1155/2020/2987696 PubMed DOI PMC

Rasova K, Prochazkova M, Tintera J, Ibrahim I, Zimova D, Stetkarova I. Motor programme activating therapy influences adaptive brain functions in multiple sclerosis: clinical and MRI study. Int J Rehabil Res. (2015) 38:49–54. doi: 10.1097/MRR.0000000000000090 PubMed DOI

Ritvo GPS, Fischer JM, Miller D, Andrews H, Paty GW, Nicholas MD, et al. . Multiple Sclerosis Quality of Life Inventory: A User's Manual. New York: The Consortium of Multiple Sclerosis Centers Health Services Research Subcommittee; (1997).

Penner IK, Raselli C, Stöcklin M, Opwis K, Kappos L, Calabrese P. The fatigue scale for motor and cognitive functions (FSMC): validation of a new instrument to assess multiple sclerosis-related fatigue. Mult Scler. (2009) 15:1509–17. doi: 10.1177/1352458509348519 PubMed DOI

Diener E, Emmons RA, Larsen RJ, Griffin S. The satisfaction with life scale. J Pers Assess. (1985) 49:71–5. doi: 10.1207/s15327752jpa4901_13 PubMed DOI

Ferenbach C. (2011). The process of psychological adjustment to multiple sclerosis: Comparing the roles of appraisals, acceptance, and cognitive fusion. The Univeristy of Edinburgh.

Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry. (1961) 4:561–71. doi: 10.1001/archpsyc.1961.01710120031004 PubMed DOI

Sosvorova L, Vitku J, Chlupacova T, Mohapl M, Hampl R. Determination of seven selected neuro- and immunomodulatory steroids in human cerebrospinal fluid and plasma using LC-MS/MS. Steroids. (2015) 98:1–8. doi: 10.1016/j.steroids.2015.01.019, PMID: PubMed DOI

R Core Team (2022). R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. Available at: https://www.R-project.org/

TIBCO Statistica® (2017). Computer program (13.3.0). TIBCO Software Inc.29.

Broch L, Simonsen CS, Flemmen H, Berg-Hansen P, Skardhamar Å, Ormstad H, et al. . High prevalence of fatigue in contemporary patients with multiple sclerosis. Mult Scler J Exp Transl Clin. (2021) 7:205521732199982. doi: 10.1177/2055217321999826 PubMed DOI PMC

Kobelt G, Langdon D, Jönsson L. The effect of self-assessed fatigue and subjective cognitive impairment on work capacity: the case of multiple sclerosis. Mult Scler. (2019) 25:740–9. doi: 10.1177/1352458518769837 PubMed DOI PMC

NICE guideline (NG220) (2022). Multiple sclerosis in adults: management. Available at: https://www.nice.org.uk/guidance/ng220/chapter/Recommendations#providing-information-and-support

Galland-Decker C, Marques-Vidal P, Vollenweider P. Prevalence and factors associated with fatigue in the Lausanne middle-aged population: a population-based, cross-sectional survey. BMJ Open. (2019) 9:e027070. doi: 10.1136/bmjopen-2018-027070, PMID: PubMed DOI PMC

Jakobsen JC, Gluud C, Wetterslev J, Winkel P. When and how should multiple imputation be used for handling missing data in randomised clinical trials—a practical guide with flowcharts. BMC Med Res Methodol. (2017) 17:162. doi: 10.1186/s12874-017-0442-1 PubMed DOI PMC

Skivington K, Matthews L, Simpson SA, Craig P, Baird J, Blazeby JM, et al. . A new framework for developing and evaluating complex interventions: update of Medical Research Council guidance. BMJ. (2021) 374:n2061. doi: 10.1136/bmj.n2061 PubMed DOI PMC

Kos D, Duportail M, D'Hooghe M, Nagels G, Kerckhofs E. Multidisciplinary fatigue management programme in multiple sclerosis: a randomized clinical trial. Mult Scler. (2007) 13:996–1003. doi: 10.1177/1352458507078392 PubMed DOI

Kalb R, Brown TR, Coote S, Costello K, Dalgas U, Garmon E, et al. . Exercise and lifestyle physical activity recommendations for people with multiple sclerosis throughout the disease course. Mult Scler. (2020) 26:1459–69. doi: 10.1177/1352458520915629 PubMed DOI PMC